NewGenIvf Group Ltd
NewGenIvf Group Ltd is a U.S.-listed, Thailand-based diversified company organized around reproductive health services, digital asset and AI-related activities, real estate development in the UAE, and health and longevity products. Its operating structure includes NewGenProperty, NewGenDigital, and NewGenSup, alongside its legacy IVF and assisted reproductive treatment business across Asia.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueLegacy IVF and assisted reproductive treatment services across Asia.
NewGenDigital activities spanning AI, prediction markets, and decentralized-finance themes.
Development projects in Ras Al Khaimah, United Arab Emirates.
NewGenSup products and solutions focused on wellness and longevity.
Products
Reported · share of revenue- IVF Treatment Service82.6 %
- Fertility Referral Services17.4 %
Source: 20-F FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company serves patients seeking fertility and assisted reproduction services across Asia, where clinic access, medical expertise, and patient outcomes are central purchase drivers. It also targets counterparties and partners in digital asset and AI-related activities, as well as property development customers and tenants linked to its UAE real estate projects. For NewGenSup, the customer base is oriented toward consumers or distribution partners seeking health and longevity solutions.
Individuals and couples buying IVF and assisted reproduction services for clinical treatment and family planning.
Patients traveling into Asia for reproductive treatment where specialized clinic access and cost matter.
Property buyers, tenants, and development partners connected to projects in Ras Al Khaimah.
Investment or commercial partners participating in NewGenDigital initiatives and related transactions.
Customers purchasing health and longevity products through NewGenSup channels.
Strategy
NewGenIVF is building a multi-platform model that combines healthcare, digital assets, and property development rather than relying on a single operating line. The stated direction is to use strategic investments and geographic hubs, especially in the UAE, to create optionality across medical tourism, real estate, and digital-technology themes. This makes the business more diversified in concept, but also more dependent on execution across distinct industries.
Creates a geographic base for real estate and adjacent healthcare demand.
Adds exposure to higher-growth digital themes and strategic investments.
Broadens the company beyond fertility services into wellness-related products.
Geography
2025The company is headquartered in Thailand and reports a legacy IVF and assisted reproductive treatment business across Asia. It also has a real estate development footprint in Ras Al Khaimah, United Arab Emirates, which links the business to the GCC market and to regional medical-tourism infrastructure. Its geography therefore spans Asia for healthcare services and the UAE for property development and related strategic initiatives.
Share of the revenue the company reports by geography.
Risks
The business is exposed to execution risk because it spans several unrelated sectors, each with different operating, regulatory, and capital requirements. Its fertility services face healthcare competition and regulatory complexity, while digital assets and AI initiatives add technology, partner, and market-acceptance risk. Real estate development in the UAE also introduces project, funding, and demand-cycle risk.
- Cross-business execution riskImpact: HighLikelihood: High
The company operates in healthcare, property, and digital assets, which require different capabilities and controls.
Exposure - Capital structure and dilution riskImpact: HighLikelihood: High
Convertible notes, share issuance, and financing terms can affect dilution and flexibility.
Exposure: Recent note exchange and share-based consideration in acquisitions.
- Healthcare and fertility regulationImpact: HighLikelihood: Medium
Assisted reproduction is regulated and sensitive to clinical standards, licensing, and local laws.
Exposure: IVF and assisted reproductive treatment services in Asia.
- Real estate project and funding riskImpact: HighLikelihood: Medium
Development projects require capital, approvals, and successful lease or sale absorption.
Exposure: Ras Al Khaimah real estate projects.
- Digital-asset volatility and partner riskImpact: MediumLikelihood: High
Digital asset and DeFi initiatives can be highly sensitive to pricing, adoption, and counterparty performance.
Exposure: NewGenDigital and strategic investment in K25.ai.
Accounting
Judgemental itemsAmended debt terms and exchange features may require careful liability and derivative assessment.
Impact: Can affect interest expense, fair value changes, and dilution analysis
Equity issued in transactions must be measured and classified correctly.
Impact: Affects acquisition accounting and share count
Investments in digital-asset-related businesses or tokens can require fair value or impairment judgments.
Impact: Can create volatility in reported gains, losses, or carrying values
Project costs, capitalization, and stage-of-completion judgments affect margins and asset balances.
Impact: Influences inventory, development assets, and revenue timing
Similar listed companies
Publicly listed companies with a comparable business focus.
Ohmyhome Ltd
OMH · Real Estate Agents & Managers (For Others)
Ohmyhome Ltd is a Cayman Islands holding company with operating roots in Singapore, built around property-related services and digital marketing services.
Adlai Nortye Group Ltd.
ANL · Pharmaceutical Preparations
Harrison Global Holdings Inc.
Services-Allied To Motion Picture Production
Meihua International Medical Technologies Co., Ltd.
MHUAF · Surgical & Medical Instruments & Apparatus
DarkIris Inc.
DKI · Services-Prepackaged Software
BGM Group Ltd.
BGM · Pharmaceutical Preparations
BGM Group Ltd is a Cayman Islands holding company with operating businesses primarily conducted through subsidiaries and variable interest entities in mainland China.
Last updated: 28/09/2026